Supreme Court decided not to grant certiorari in Teva Pharms. v. GlaxoSmithKline which comes after the Solicitor General and four amicus briefs urged the Court to take action. The Solicitor General emphasized FDA regulations govern what may and may not be carved out of a skinny label.